| Active substance(s) | Rivastigmine |
| Country of admission | gb |
| Marketing authorisation holder | Teva Pharma B.V. |
| ATC Code | N06DA03 |
| Pharmacological groups | Anti-dementia drugs |
Rivastigmine Teva belongs to a class of substances called cholinesterase inhibitors.
Rivastigmine Teva is used for the treatment of memory disorders in patients with Alzheimer?s dementia.
Rivastigmine Teva is used for the treatment of dementia in patients with Parkinson?s disease.
Before taking Rivastigmine Teva it is important that you read the following section and discuss any questions you might have with your doctor.
If any of these apply to you, your doctor may need to monitor you more closely while you are on this medicine.
The use of Rivastigmine Teva in children and adolescents (age below 18 years) is not recommended.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
If you have to undergo surgery whilst taking Rivastigmine Teva, you should inform the doctor before you are given any anaesthetics, because Rivastigmine Teva may exaggerate the effects of some muscle relaxants during anaesthesia.
Rivastigmine Teva should not be given at the same time as other medicines with similar effects to Rivastigmine Teva. Rivastigmine Teva might interfere with antiocholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson?s disease or to prevent travel sickness).
It is preferable to avoid the use of Rivastigmine Teva during pregnancy, unless clearly necessary. Tell your doctor if you become pregnant during treatment. Women on Rivastigmine Teva should not breast-feed. Ask your doctor or pharmacist for advice before taking any medicine.
Your illness may impair your ability to drive or operate machinery and you must not carry out these activities unless your doctor tells you it is safe to do so. Rivastigmine Teva may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.If you experience such effects, you should not drive or operate machinery.
Always take Rivastigmine Teva exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Swallow the capsules whole with a drink, without opening or crushing them.
You should take Rivastigmine Teva twice a day with food (in the morning and evening).
Your doctor will tell you what dosage of Rivastigmine Teva to take, starting with a low dose and gradually increasing, depending on how you respond to the treatment. The highest dose that should be taken is 6.0 mg twice a day. If you have not taken Rivastigmine Teva for several days, do not take the next dose until you have talked to your doctor.
To benefit from your medicine you should take it every day.
Tell your caregiver that you are taking Rivastigmine Teva.
This medicine should only be prescribed by a specialist and your doctor should regularly review whether it is having the desired effect. Your doctor will monitor your weight whilst you are taking this medicine.
If you take more Rivastigmine Teva than you should
Tell your doctor if you find you have accidentally taken more Rivastigmine Teva than you are told to. You may require medical attention. Some people who have accidentally taken too much Rivastigmine Teva have experienced nausea, vomiting, diarrhoea, high blood pressure and hallucinations. Slow heart beat and fainting may also occur.
If you find you have forgotten to take your dose of Rivastigmine Teva, wait and take the next dose at the usual time.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Rivastigmine Teva can cause side effects, although not everybody gets them. You may tend to get side effects more frequently when you start taking your medicine or increase to a higher dose. Side effects will gradually disappear most probably as your body becomes used to the medicine.
The following side effects have been reported at the approximate frequencies shown:
Very common affects more than 1 user in 10 Common affects 1 to 10 users in 100 Uncommon affects 1 to 10 users in 1,000 Rare affects 1 to 10 users in 10,000 Very Rare affects less than 1 user in 10,000 Unknown frequency cannot be estimated from the available data
Some cases of severe vomiting were associated with rupture of the gullet (swallowing tube).
Patients with dementia associated with Parkinson?s disease experience some side effects more frequently and also some additional side effects: trembling (very common), difficulty in sleeping, anxiety, restlessness, worsening of Parkinson?s disease or development of similar symptoms (muscle stiffness, difficulty in carrying out movements), abnormally slow or uncontrollable movements, slow heart beat, too much saliva and dehydration (common), irregular heart beat and poor control of movements (uncommon).
Should such symptoms occur, contact your doctor as you may need medical assistance.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Do not use Rivastigmine Teva after the expiry date that is stated on the carton. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is rivastigmine
Rivastigmine Teva 1.5 mg hard capsules contains 1.5 mg rivastigmine as rivastigmine hydrogen tartrate
Rivastigmine Teva 3 mg hard capsules contains 3 mg rivastigmine as rivastigmine hydrogen tartrate Rivastigmine Teva 4.5 mg hard capsules contains 4.5 mg rivastigmine as rivastigmine hydrogen tartrate
Rivastigmine Teva 6 mg hard capsules contains 6 mg rivastigmine as rivastigmine hydrogen tartrate
The other ingredients are:
Capsule contents - microcrystalline cellulose, hypromellose, colloidal silicon dioxide, magnesium stearate.
Capsule shell ? titanium dioxide (E171), gelatin and ink used for imprinting Black S-1-17822/S-1-17823 (shellac glaze-45% in ethanol containing iron oxide black, N-butyl alcohol, isopropyl alcohol, propylene alcohol and ammonium hydroxide). In addition, Rivastigmine Teva 3 mg, 4.5 mg and 6 mg hard capsules contain red iron oxide (E172) and yellow iron oxide (E 172).
Hard capsule
Rivastigmine Teva hard capsules are available in blister packs of 28, 56 and 112 capsules, perforated blisters containing 50 x 1 capsules, and bottles containing 250 capsules.
Teva Pharma B.V.
Computerweg 10, 3542 DR Utrecht
The Netherlands
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13,
4042 Debrecen,
Hungary
Or:
TEVA Pharmaceutical Works Private Limited Company
H-2100 Gödöll-,
Táncsics Mihály út 82
Hungary
Or:
TEVA UK Ltd
Brampton Road,
Hampden Park,
Eastbourne,
East Sussex,
BN22 9AG
United Kingdom
Or:
Pharmachemie B.V.
Swensweg 5,
Postbus 552,
2003 RN Haarlem
The Netherlands
Or:
TEVA Santé Sa,
Rue Bellocier, 89107,
Sens,
France
Or
IVAX Pharmaceuticals s.r.o.
Ostravska 29, c.p. 305
747 70 Opava-Komarov
Czech Republic
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
BelgiëBelgiqueBelgien Teva Pharma Belgium N.V.S.A. TelTél 32 3 820 73 73 LuxembourgLuxemburg Teva Pharma Belgium S.A. TélTel 32 3 820 73 73
Te 359 2 489 95 82 Magyarország Teva Magyarország Zrt Tel. 36 1 288 64 00 eská republika Teva Pharmaceuticals CR, s.r.o. Tel 420 251 007 111 Malta Teva .. el 30 210 72 79 099 Danmark Teva Denmark AS Tlf 45 44 98 55 11 Nederland Teva Nederland B.V. Tel 31 0 800 0228400 Deutschland Teva Generics GmbH Tel 49 351 834 0 Norge Teva Sweden AB Tlf 46 42 12 11 00 Österreich Teva Generics GmbH Tel 49 351 834 0 Eesti Teva Eesti esindus UAB Sicor Biotech Eesti filiaal Tel 372 611 2409 Teva .. 30 210 72 79 099 Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel. 48 22 345 93 00
España Teva Genéricos Española, S.L.U Tél 34 91 387 32 80 Portugal Teva Pharma - Produtos Farmacêuticos Lda Tel 351 214 235 910 France Teva Santé Tél 33 1 55 91 7800 România Teva Pharmaceuticals S.R.L Tel 4021 230 65 24 Ireland Teva Pharmaceuticals Ireland Tel 353 042 9395 892 Slovenija Pliva Ljubljana d.o.o. Tel 386 1 58 90 390 Ísland Teva UK Limited Sími 44 1323 501 111. Slovenská republika Teva Pharmaceuticals Slovakia s.r.o. Tel 421 2 5726 7911 Italia Teva Italia S.r.l. Tel 39 0289179805 SuomiFinland Teva Sweden AB PuhTel 46 42 12 11 00 Teva .. 30 210 72 79 099 Sverige Teva Sweden AB Tel 46 42 12 11 00 Latvija UAB Sicor Biotech filile Latvij Tel 371 67 784 980 United Kingdom Teva UK Limited Tel 44 1323 501 111 Lietuva UAB Sicor Biotech Tel 370 5 266 02 03
This leaflet was last approved in {MM/YYYY}.
Last updated on 19.08.2022
The following drugs also contain the active ingredient Rivastigmine . Consult your doctor about a possible substitute for Rivastigmine Teva 1.5 mg hard capsules
Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.
All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.
Symptoms, causes, and treatments for common diseases and injuries.
The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.
© medikamio
